+77.3%
CURE vs SPY
+21.3%
+56.0%
-31.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | +1.0% | -0.5% | -0.3% |
| 7D | +2.9% | +0.3% | +2.6% | +2.6% |
| 30D | +20.1% | +0.2% | +19.9% | +19.9% |
| 3M | +56.1% | +2.8% | +53.3% | +52.4% |
| 6M | +26.1% | +14.3% | +11.8% | +4.9% |
| YTD | +27.4% | +14.0% | +13.4% | +5.7% |
| All | +77.3% | +21.3% | +56.0% | +26.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SPY.
Daily Out/Under-Performance
Portfolio return minus SPY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling